Ryan Motte, PharmD, CSP, reviewed the global cancer burden among men and its projected trajectory to 2050, highlighting the ...

FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

The following is a summary of “Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival ...

Cushing disease treatment outcomes were improved among patients with normalized late-night salivary and mean urinary free cortisol levels.

Fewer people who gave birth in 2022 received adequate prenatal care compared to the prior year, and more Bay Staters used ...

Two researchers from Huntsman Cancer Institute at the University of Utah (the U) have discovered a gene variant found in high ...

You know that moment when life takes an unexpected turn? That’s exactly what happened when I started researching stem cell ...

Although intravitreal faricimab helped to decrease central subfield thickness (CST) in patients with eyes previously treated ...

John O. Mascarenhas, MD, and Kapila Viges discuss how the latest research is transforming MPN care by aligning research with ...

A Helsinki University Hospital study found diabetes, glycemic control, or insulin therapy did not significantly affect ...

Demonstrating improvements in patient quality of life using patient-reported outcomes are important for treatments for myeloproliferative neoplasms (MPNs), said Jennifer Vaughn, MD, of The Ohio State ...

One in eight U.S. women will be diagnosed with breast cancer during their lifetime, and many of these patients will undergo a ...